Grace Therapeutics, Inc. (GRCE) Revenue 2022–2023
Grace Therapeutics, Inc. (GRCE) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$100.0MFY2023 · since FY2022: $196,000 → $100.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | $100.0M | +50920.4% |
| FY2022 | $196,000 | — |
Source: SEC XBRL filings · For reference only · Not investment advice